Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AJ 2615

Known as: AJ-2615 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
AIMS Graft spasm may develop during coronary artery bypass grafting and reversal of spasm is still challenging. The purpose of… Expand
Is this relevant?
1994
1994
A multicenter, open-label trial in Japan examined the efficacy, safety, and optimal dose of monatepil (AJ-2615) as monotherapy… Expand
Is this relevant?
1993
1993
We studied the in vitro vascular relaxant properties of AJ-2615, (+/-)-N-[6,11-dihydrodibenzo[b,e]-thiepin-11-yl]-4-[4… Expand
Is this relevant?
1993
1993
SUMMARY 1. To characterize the anti-arrhythmic properties of a new calcium antagonist, monotepil, AJ-2615, the preventive… Expand
Is this relevant?
1993
1993
1. To characterize the anti-arrhythmic properties of a new calcium antagonist, monatepil [corrected], AJ-2615, the preventive… Expand
Is this relevant?
1993
1993
The effects of a new calcium antagonist, AJ-2615, on progression of atherosclerosis were investigated in rabbits fed a diet high… Expand
Is this relevant?
1993
1993
The antihypertensive effect of AJ-2615 [(+/-)-N-(6,11-dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-fluoro phenyl)-1… Expand
Is this relevant?
1993
1993
AJ-2615, a dihydrodibenzothiepin derivative, at 10(-4) M inhibited the peak ICa amplitude of an identifiable Achatina neurone… Expand
Is this relevant?
1993
1993
Effects of monatepil ([(+/-)-N-(6,11-dihydrodibenzo[b, e]thiepin-11-yl)-4-(p-fluorophenyl)-1-piperazinebutyramide]m aleate, AJ… Expand
Is this relevant?